Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-07-003656
Filing Date
2007-06-14
Accepted
2007-06-14 14:32:22
Documents
10
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 ALKERMES, INC. b65550ake10vk.htm 10-K 1467203
2 EX-10.16(B) AMENDMENT TO THE LICENSE AND COLLABORATION AGREEMENT b65550akexv10w16xby.txt EX-10.16(B) 10895
3 EX-10.16(C) AMENDMENT TO THE SUPPLY AGREEMENT b65550akexv10w16xcy.txt EX-10.16(C) 18932
4 EX-21.1 SUBSIDIARIES OF THE REGISTRANT b65550akexv21w1.htm EX-21.1 3043
5 EX-23.1 CONSENT OF DELOITTE & TOUCHE LLP b65550akexv23w1.htm EX-23.1 1818
6 EX-31.1 SECTION 302 CERTIFICATION OF CEO b65550akexv31w1.htm EX-31.1 6248
7 EX-31.2 SECTION 302 CERTIFICATION OF CFO b65550akexv31w2.htm EX-31.2 6256
8 EX-32.1 SECTION 906 CERTIFICATION OF CEO & CFO b65550akexv32w1.htm EX-32.1 4087
9 GRAPHIC b65550akb6555003.gif GRAPHIC 9415
10 GRAPHIC b65550akb6555001.gif GRAPHIC 2764
  Complete submission text file 0000950135-07-003656.txt   1536852
Mailing Address
Business Address 88 SIDNEY ST CAMBRIDGE MA 02139-4136 617-494-0171
ALKERMES INC (Filer) CIK: 0000874663 (see all company filings)

EIN.: 232472830 | State of Incorp.: PA | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-14131 | Film No.: 07919674
SIC: 2834 Pharmaceutical Preparations